This is the first study to examine if transcranial infrared laser stimulation (TILS) improves cognition in older euthymic bipolar patients, who exhibit greater cognitive decline than is expected for age-matched controls. TILS is a non-invasive novel form of photobiomodulation that augments prefrontal oxygenation and improves cognition in young adults by upregulating the mitochondrial respiratory enzyme cytochrome-c-oxidase. We used a crossover sham-controlled design to examine if TILS to bilateral prefrontal cortex produces beneficial effects on cognition in 5 euthymic bipolar patients (ages 60-85). We measured cognitive flexibility, verbal fluency, working memory, sustained attention and impulsivity with tasks that have been shown to differentiate between healthy older adults and older bipolar adults. We found TILS-induced improvements in cognitive performance on the tasks that measure cognitive flexibility and impulsivity, after 5 weekly sessions of TILS. We concluded that TILS appeared both safe and effective in helping alleviate the accelerated cognitive decline present in older bipolar patients.
DevSIMcKennaBSSutherlandAN, et al.Increased cerebral blood flow associated with better response inhibition in bipolar disorder. J Int Neuropsychol Soc. 2015;21(2):105–115.
3.
TomaSMacIntoshBJSwardfagerWGoldsteinBI. Cerebral blood flow in bipolar disorder: a systematic review. J Affect Dis. 2018;241:505–513.
4.
MansurRBChaDSAsevedoEMcIntyreRSBrietzkeE. Selfish brain and neuroprogression in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2013;43:66–71.
5.
SajatovicMStrejilevichSAGildengersAG, et al.A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force. Bipolar Disord. 2015;17(7):689–704.
6.
MartinoDJStrejilevichSAManesF. Neurocognitive functioning in early-onset and late-onset older patients with euthymic bipolar disorder. Int J Geriatr Psychiatry. 2013;28(2):142–148.
7.
VietaETorrentC. Functional remediation: the pathway from remission to recovery in bipolar disorder. World Psychiatry. 2016;15(3):288–289.
8.
ClayHBSillivanSKonradiC. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci. 2011;29(3):311–324.
9.
CataldoAMMcPhieDLLangeNT, et al.Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am J Pathol. 2010;177(2):575–585.
10.
TsujiiNOtsukaIOkazakiS, et al.Mitochondrial DNA copy number raises the potential of left frontopolar hemodynamic response as a diagnostic marker for distinguishing bipolar disorder from major depressive disorder. Front Psychiatry. 2019;10:312.
11.
FriesGRBauerIEScainiG, et al.Accelerated hippocampal biological aging in bipolar disorder. Bipolar Disord. 2020;22(5):498–507.
12.
LiuHZhangJ. Cerebral hypoperfusion and cognitive impairment: the pathogenic role of vascular oxidative stress. Int J Neurosci. 2012;122(9):494–499.
13.
Gonzalez-LimaFBarksdaleBRRojasJC. Mitochondrial respiration as a target for neuroprotection and cognitive enhancement. Biochem Pharmacol. 2014;88(4):584–593.
14.
Gonzalez-LimaFAuchterA. Protection against neurodegeneration with low-dose methylene blue and near-infrared light. Front Cell Neurosci. 2015;9:179.
15.
RojasJCGonzalez-LimaF. Neurological and psychological applications of transcranial lasers and LEDs. Biochem Pharmacol. 2013;86(4):447–457.
16.
WangXTianFReddyDD, et al.Up-regulation of cerebral cytochrome-c-oxidase and hemodynamics by transcranial infrared laser stimulation: a broadband near-infrared spectroscopy study. J Cereb Blood Flow Metab. 2017;37(12):3789–3802.
HolmesEBarrettDWLiuHGonzalez-LimaF. Cognitive enhancement by transcranial photobiomodulation augments cerebrovascular oxygenation of the prefrontal cortex. Front Neurosci. 2019;13:1129.
19.
Wong-RileyMT. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 1989;12(3):94–101.
20.
WangXTianFSoniSSGonzalez-LimaFLiuH. Interplay between up-regulation of cytochrome-c-oxidase and hemoglobin oxygenation induced by near-infrared laser. Sci Rep. 2016;6:30540.
21.
SalehpourFMajdiAPazhuhiM, et al.Transcranial photobiomodulation improves cognitive performance in young healthy adults: a systematic review and meta-analysis. Photobiomodul Photomed Laser Surg. 2019;37(10):635–643.
22.
HwangJCastelliDMGonzalez-LimaF. Cognitive enhancement by transcranial laser stimulation and acute aerobic exercise. Lasers Med Sci. 2016;31(6):1151–1160.
23.
BlancoNJMaddoxWTGonzalez-LimaF. Improving executive function using transcranial infrared laser stimulation. J Neuropsychol. 2017;11(1):14–25.
24.
BlancoNJSaucedoCLGonzalez-LimaF. Transcranial infrared laser stimulation improves rule-based, but not information-integration, category learning in humans. Neurobiol Learn Mem. 2017;139:69–75.
25.
VargasEBarrettDWSaucedoCL, et al.Beneficial neurocognitive effects of transcranial laser in older adults. Lasers Med Sci. 2017;32(5):1153–1162.
26.
Gonzalez-LimaFBarrettDW. Augmentation of cognitive brain function with transcranial lasers. Front Syst Neurosci. 2014;8:36.
27.
PoljsakB. Strategies for reducing or preventing the generation of oxidative stress. Oxid Med Cell Longev. 2011;2011:194586.
SalehpourFMahmoudiJKamariFSadigh-EteghadSRastaSHHamblinMR. Brain photobiomodulation therapy: a narrative review. Mol Neurobiol. 2018;55(8):6601–6636.
30.
BarrettDWGonzalez-LimaF. Transcranial infrared laser stimulate produces beneficial cognitive and emotional effects in humans. Neuroscience. 2013;230:13–23.
31.
RojasJCGonzalez-LimaF. Transcranial Low-Level Laser (Light) therapy for neurocognitive enhancement. In: de SousaMHamblinMRAgrawalT, eds. Handbook of Low-Level Laser Therapy. Jenny Stanford Publishing; 2017:1093–1112.
32.
SchifferFJohnstonALRavichandranC, et al.Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety. Behav Brain Funct. 2009;5(1):46.
33.
CassanoPCusinCMischoulonD, et al.Near-infrared transcranial radiation for major depressive disorder: proof of concept study. Psychiatry J. 2015;2015:352979.
34.
DisnerSGBeeversCGGonzalez-LimaF. Transcranial laser stimulation as neuroenhancement for attention bias modification in adults with elevated depression symptoms. Brain Stimul. 2016;9(5):780–787.
35.
CassanoPPetrieSRMischoulonD, et al.Transcranial photobiomodulation for the treatment of major depressive disorder. The ELATED-2 pilot trial. Photomed Laser Surg.2018;36(12):634–646.
36.
CarneiroAMCPoianiGCZaninnotoAL, et al.Transcranial photobiomodulation therapy in the cognitive rehabilitation of patients with cranioencephalic trauma. Photobiomodul Photomed Laser Surg. 2019;37(10):657–666.
37.
MaielloMLosiewiczOMBuiE, et al.Transcranial photobiomodulation with near-infrared light for generalized anxiety disorder: a pilot study. Photobiomodul Photomed Laser Surg. 2019;37(10):644–650.
38.
MannuPSaccaroLFSperaVCassanoP. Transcranial photobiomodulation to augment lithium in bipolar-I disorder. Photobiomodul Photomed Laser Surg. 2019;37(10):577–578.
39.
SaltmarcheAENaeserMAHoKFHamblinMRLimL. Significant improvement in cognition in mild to moderately severe dementia cases treated with transcranial plus intranasal photobiomodulation: case series report. Photomed Laser Surg. 2017;35(8):432–441.
40.
BermanMHHalperJPNicholsTWJarrettHLundyAHuangJH. Photobiomodulation with near infrared light helmet in a pilot, placebo controlled clinical trial in dementia patients testing memory and cognition. J Neurol Neurosci. 2017;8(1):176.
41.
SalehpourFHamblinMRDiDuroJO. Rapid reversal of cognitive decline, olfactory dysfunction, and quality of life using multi-modality photobiomodulation therapy: case report. Photobiomodul Photomed Laser Surg. 2019;37(3):159–167.
42.
CassanoPCaldieraroMANortonR, et al.Reported side effects, weight and blood pressure, after repeated sessions of transcranial photobiomodulation. Photobiomodul Photomed Laser Surg. 2019;37(10):651–656.
43.
YoungRCBiggsJTZieglerVEMeyerDA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–435.
44.
KroenkeKSpitzerRLWilliamsJB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613.
45.
DelaloyeCMoyGBaudoisS, et al.Cognitive features in euthymic bipolar patients in old age. Bipolar Disord. 2009;11(7):735–743.
46.
SchouwsSNComijsHCStekML, et al.Cognitive impairment in early and late bipolar disorder. Am J Geriatr Psychiatry. 2009;17(6):508–515.
47.
SamaméCMartinoDJStrejilevichSA. A quantitative review of neurocognition in euthymic late-life bipolar disorder. Bipolar Disord. 2013;15(6):633–644.
48.
ReitanRM. The relation of the trail making test to organic brain damage. J Consult Psychol. 1955;19(5):393–394.
49.
MiskinNThesenTBarrWB, et al.Prefrontal lobe structural integrity and trail making test, part B: converging findings from surface-based cortical thickness and voxel-based lesion symptom analyses. Brain Imaging Behav. 2016;10(3):675–685.
50.
VarjacicAMantiniDDemeyereNGillebertCR. Neural signatures of Trail Making Test performance: evidence from lesion-mapping and neuroimaging studies. Neuropsychologia. 2018;115:78–87.
51.
Shibuya-TayoshiSUMIKOSumitaniSKikuchiK, et al.Activation of the prefrontal cortex during the Trail-Making Test detected with multichannel near-infrared spectroscopy. Psychiatry Clin Neurosci. 2007;61(6):616–621.
52.
DemakisGJ. Frontal lobe damage and tests of executive processing: a meta-analysis of the category test, Stroop test, and trail-making test. J Clin Exp Neuropsychol. 2004;26(3):441–450.
53.
TombaughTN. Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol. 2004;19(2):203–214.
54.
GruenewaldPJLockheadGR. The free recall of category examples. J Ex Psych. 1980;6(3):225–241.
55.
CostafredaSGFuCHPicchioniM, et al.Pattern of neural responses to verbal fluency shows diagnostic specificity for schizophrenia and bipolar disorder. BMC Psychiatry. 2011;11(1):18.
56.
NishimuraYTakahashiKOhtaniTIkeda-SugitaRKasaiKOkazakiY. Dorsolateral prefrontal hemodynamic responses during a verbal fluency task in hypomanic bipolar disorder. Bipolar Disord. 2015;17(2):172–183.
57.
RosvoldHEMirskyAFSarasonIBransomeEDBeckLH. A continuous performance test of brain damage. J Consult Psychol. 1956;20:343–350.
58.
SoléBJiménezETorrentC, et al.Cognitive impairment in bipolar disorder: treatment and prevention strategies. Int J Neuropsychopharmacol. 2017;20(8):670–680.
59.
AllinMPGMarshallNSchulzeK, et al.A functional MRI study of verbal fluency in adults with bipolar disorder and their unaffected relatives. Psychol Med. 2010;40(12):2025–2035.
60.
YoshimuraSOkamotoYOnodaK, et al.Cognitive behavioral therapy for depression changes medial prefrontal and ventral anterior cingulate cortex activity associated with self-referential processing. Soc Cogn Affect Neurosci. 2014;9(4):487–493.
61.
SwannAC. Mechanisms of impulsivity in bipolar disorder and related illness. Epidemiol Psychiatr Sci. 2010;19(2):120–130.
62.
SaddichhaSSchuetzC. Is impulsivity in remitted bipolar disorder a stable trait? A meta-analytic review. Compr Psychiatry. 2014;55(7):1479–1484.
63.
MuhtadieLJohnsonSLCarverCSGotlibIHKetterTA. A profile approach to impulsivity in bipolar disorder: the key role of strong emotions. Acta Psychiatr Scand. 2014;129(2):100–108.
64.
MasonLO’SullivanNMontaldiDBentallRPEl-DeredyW. Decision making and trait impulsivity in bipolar disorder are associated with reduced prefrontal regulation of striatal reward valuation. Brain. 2014;137(8):2346–2355.
65.
TrostSDiekhofEKZvonikK, et al.Disturbed anterior prefrontal control of the mesolimbic reward system and increased impulsivity in bipolar disorder. Neuropsychopharmacology. 2014;39(8):1914–1923.
66.
HagenKEhlisACHaeussingerFB, et al.Activation during the Trail Making Test measured with functional near-infrared spectroscopy in healthy elderly subjects. Neuroimage. 2014;85:583–591.
67.
MüllerLDGuhnAZellerJB, et al.Neural correlates of a standardized version of the trail making test in young and elderly adults: a functional near-infrared spectroscopy study. Neuropsychologia. 2014;56:271–279.
68.
Dell’OssoBCinnanteCDi GiorgioA, et al.Altered prefrontal cortex activity during working memory task in bipolar disorder: a functional magnetic resonance imaging study in euthymic bipolar I and II patients. J Affect Disord. 2015;184:116–122.
69.
BrunoniARVanderhasseltMA. Working memory improvement with noninvasive brain stimulation of the dorsolateral prefrontal cortex: a systematic review and meta-analysis. Brain Cogn. 2014;86:1–9.
HosokawaTMomoseTKasaiK. Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33(2):243–250.
72.
BrooksJOIIIHoblynJCWoodardSARosenACKetterTA. Corticolimbic metabolic dysregulation in euthymic older adults with bipolar disorder. J Psychiatr Res. 2009;43(5):497–502.
73.
HaarmanBCBRiemersma-Van der LekRFde GrootJC, et al.Neuroinflammation in bipolar disorder–A [11C]-(R)-PK11195 positron emission tomography study. Brain Behav Immun. 2014;40:219–225.
74.
SchecklmannMDreslerTBeckS, et al.Reduced prefrontal oxygenation during object and spatial visual working memory in unipolar and bipolar depression. Psychiatry Res. 2011;194(3):378–384.
75.
ChepenikLGRaffoMHampsonM, et al.Functional connectivity between ventral prefrontal cortex and amygdala at low frequency in the resting state in bipolar disorder. Psychiatry Res. 2010;182(3):207–210.
76.
AnticevicABrumbaughMSWinklerAM, et al.Global prefrontal and fronto-amygdala dysconnectivity in bipolar I disorder with psychosis history. Biol Psychiatry. 2013;73(6):565–573.
77.
McKennaBSSutherlandANLegenkayaAPEylerLT. Abnormalities of brain response during encoding into verbal working memory among euthymic patients with bipolar disorder. Bipolar Disord. 2014;16(3):289–299.
78.
Alonso-LanaSGoikoleaJMBonninCM, et al.Structural and functional brain correlates of cognitive impairment in euthymic patients with bipolar disorder. PLoS One. 2016;11(7):e0158867.
79.
MohanARobertoAJMohanA, et al.Focus: the aging brain: the significance of the default mode network (DMN) in neurological and neuropsychiatric disorders: a review. Yale J Biol Med. 2016;89(1):49.
